A pilot, prospective, open-label study to evaluate the safety and efficacy of Kaletra [lopinavir/ritonavir] monotherapy in HIV/HCV [hepatitis C virus] co-infected subjects.

Trial Profile

A pilot, prospective, open-label study to evaluate the safety and efficacy of Kaletra [lopinavir/ritonavir] monotherapy in HIV/HCV [hepatitis C virus] co-infected subjects.

Completed
Phase of Trial: Phase III

Latest Information Update: 29 May 2012

At a glance

  • Drugs Lopinavir/ritonavir (Primary)
  • Indications HIV infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 29 May 2012 Actual end date Apr 2011 added as reported by ClinicalTrials.gov.
    • 29 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top